Medicare
Our members provide health care to the more than 62 million Medicare beneficiaries. We urge you to include in year-end legislation an extension of the congressionally-enacted moratorium on the application of the Medicare sequester cuts into 2021 and through the duration of the public health…
As Congress continues to negotiate a year-end spending package and more COVID-19 relief, we’re continuing to keep you updated on the latest issues. This is our third Action Alert related to the lame-duck session, and information and resources related to our priority issues are included below.
Reps. Bradley Schneider, D-Ill., and David McKinley, R-W.Va., introduced the Medicare Sequester COVID Moratorium Act, AHA-supported legislation that would extend the moratorium on the Medicare sequester cuts through the COVID-19 pandemic.
Congress is back in Washington, D.C., and sprinting to the finish line to complete its end-of-the-year work during the “lame-duck” session. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11.
Congress is back in Washington, D.C., and sprinting to the finish line to complete its end-of-the-year work during the “lame-duck” session. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11.
As urged by the AHA, the Centers for Medicare & Medicaid Services gave hospitals facing a surge in COVID-19 patients expanded flexibility to care for Medicare patients outside their walls.
The Centers for Medicare & Medicaid Services issued a final rule revising the requirements for organ procurement organizations that participate in the Medicare and Medicaid programs, as required by an executive order last year.
The Centers for Medicare & Medicaid Services (CMS) Nov. 20 released an interim final rule implementing the Most Favored Nation (MFN) Model, a new payment model through the Center for Medicare and Medicaid Innovation (CMMI) that will cut Medicare Part B payments for certain drugs to the lowest…
The Centers for Medicare & Medicaid Services announced Medicare coverage for monoclonal antibody therapies, with no beneficiary cost-sharing for the duration of the COVID-19 public health emergency. CMS said the coverage will apply to bamlanivimab, the Lilly therapeutic that earned an emergency…
Congress is back in Washington, D.C., for its “lame-duck” session, in which lawmakers will take up pressing, end-of-year business. Funding for the federal government, as well as other key health care provisions, are set to expire Dec. 11. It is imperative that we work to ensure that hospitals and…